Alfacidole Soft Capsules 0.5 Micrograms (Alfacalcidol)

Adult dosage

Chronic renal failure and osteoporosis: Administer 0.5 to 1 µg of alfacalcidol orally once daily. Hypoparathyroidism and other diseases due to vitamin D metabolism abnormalities: Administer 1 to 4 µg of this medicine orally once daily.

Children's dosage

Osteoporosis: Administer 0.01 to 0.03 µg of alfacalcidol orally once daily per kg of body weight. Other diseases: Administer 0.05 to 0.1 µg of this medicine orally once daily per kg of body weight.

This medication should not be taken by patients with hypercalcemia, hyperphosphatemia, hypermagnesemia, or those with excessive levels of calcium and phosphorus in the blood. It should also be avoided by patients whose blood is excessively alkaline or who exhibit symptoms of vitamin D toxicity. Individuals with hypersensitivity to this drug should refrain from taking it. While on this medication, avoid taking it alongside drugs that increase the risk of hypercalcemia, such as magnesium-containing preparations, vitamin D and its derivatives, calcium-containing preparations, or certain diuretics. If breastfeeding, the safety of this medication has not been established, so it should be avoided if possible; if it must be taken, breastfeeding should be avoided. Women who are pregnant or may become pregnant should consult a doctor before taking this medication as it may be harmful to the fetus. Children, the elderly, individuals taking specific medications, and those with a history of kidney stones should consult a healthcare professional before taking this drug. During the course of treatment, serum calcium levels and kidney function should be monitored regularly, and if abnormalities are found, the medication should be discontinued immediately and a doctor consulted. Symptoms of hypercalcemia, such as nausea, vomiting, headaches, muscle cramps, and decreased kidney function, may occur, so if any of these symptoms arise, seek medical attention right away. To prevent overdose, adhere to prescribed dosages, watch calcium intake carefully, and manage calcium levels through blood tests as needed. This medication should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthmatic attacks, respiratory distress accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, lightning headaches, seizures, confusion of consciousness, vision abnormalities, paralysis, urination changes.

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• abdominal pain
• discomfort in the upper abdomen
• abdominal bloating
• dyspepsia
• thirst

This medication may be sensitive to light, so it should be stored in an opaque container that blocks light. It is also important to keep it in a sealed container to prevent air or moisture entry. Doing so will help maintain the medication's effectiveness for a longer period.

Appearance

Soft capsules in a light yellow color containing a yellowish transparent oily liquid.

Package unit

180 capsules/PTP